VALVE THROMBOSIS AND MANAGEMENT

Monday, March 10, 2025

1:45 PM – 2:30 PM ET

Moderator(s)

Hasan A. Jilaihawi, MD

Professor
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure information not submitted.
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

Disclosure(s): Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI

interventional, structural, and endovascular cardiologist
Heart and Vascular Institute (HVI) at Tampa General Hospital (TGH) in Tampa, FL
Wesley Chapel, Florida, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI: No financial relationships to disclose